Positive results from PK study of VAL001
Respiratorius announces that analysis of data from the PK study has now been completed and that the results from an important biomarker are also available. The results show that VAL001 has a favorable PK profile as well as a greater histone acetylating effect compared to the reference.The tailored release profile of VAL001, which combines immediate-release properties and extended-release sodium valproate, was evaluated in a pharmacokinetic (PK) study in healthy subjects. The total plasma concentration of valproate from VAL001, with dosing twice daily, was similar to that achieved with the